Drug Allocation

Inquiries

In the course of allocation of investigational new drugs，masking of treatment contents and randomization of subject allocation are required for conducting scientific and ethical clinical trials to check the safety and validity of pharmaceuticals.

Service overview

We ensure them masked and randomization as a basic nature for conducting scientific clinical trials.

POINT1 Exceptional Experiences

We make allocation lists and allocate investigational new drugs to them，and carry out spec design of subjects including both static (stratified) and dynamic (minimization/biased coin methods) in spec allocational designs of subject and investigational new drugs with our exceptional achievements from over 1,000 trial experiences.

POINT2 Flexible Structures

We form staff teams in accord with work volumes of any size of allocations possible for their invastigational new drugs.

Flow of Use

Specification Design of Allocation List

Create a spec design of allocation lists
Preparation and Storage of Allocation List

Prepare and Store Allocation Lists，or Create Emergency Keys
Allocation of Investigational New Drugs

Check indiscernibility of investigational new drugs or allocate them.
Pre-Code break Check or Participation for Code Break Meetings

Participate for code break meetings and pre-code break checks.

FAQs about solutions and services

Quality and information security initiatives

Our pharmaceutical-related business has established a quality management system based on the concept of ISO 9001，the international standard for quality management systems，and was one of the first in the CRO industry to obtain ISO 9001 certification in 2001. Even after obtaining certification，we have continued to pursue “reliability” for more than 20 years，and we have a proven track record of success. In addition，considering the importance of the information we handle，we also thoroughly implement information security management and personal information protection under our information security policy and personal information protection policy，and have obtained ISO 27001 certification. We are committed to continuous review and improvement in order to provide reliable and appropriate quality at all times. See here (https://solution.bell.co.jp/en/solution/medical/Information) for details.

Monthly magazine Medical Express

Related case studies

Sawai Pharmaceutical Co., Ltd.
Building full trust in services towards implementation to operations based on expertise in the medical industry.
Backoffice

Medical and Health Solution